Saad F - Search Results

1

Low nuclear ErbB3 predicts biochemical recurrence in patients with prostate cancer.

Koumakpayi IH, Diallo JS, Le Page C, Lessard L, Filali-Mouhim A, Bégin LR, Mes-Masson AM, Saad F. Koumakpayi IH, et al. Among authors: saad f. BJU Int. 2007 Aug;100(2):303-9. doi: 10.1111/j.1464-410X.2007.06992.x. Epub 2007 May 26. BJU Int. 2007. PMID: 17532856

2

[Usefulness of prostate-specific antigen in the diagnosis of lymphatic metastases in cancer of the prostate].

Saad F, Bertrand P, Paquin JM, Péloquin F. Saad F, et al. Ann Chir. 1995;49(8):680-4. Ann Chir. 1995. PMID: 8561420 Clinical Trial. French.

3

Digital rectal exam following prostatectomy: is it still necessary with the use of PSA?

Lattouf JB, Saad F. Lattouf JB, et al. Among authors: saad f. Eur Urol. 2003 Apr;43(4):333-6. doi: 10.1016/s0302-2838(03)00046-0. Eur Urol. 2003. PMID: 12667712

4

UPM3: review of a new molecular diagnostic urine test for prostate cancer.

Saad F. Saad F. Can J Urol. 2005 Feb;12 Suppl 1:40-3; discussion 99-100. Can J Urol. 2005. PMID: 15780164 Review.

5

Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature.

Saad F, Finelli A, Dranitsaris G, Goldenberg L, Bagnell S, Gleave M, Fleshner N; Canadian surgical wait times (SWAT) initiative. Saad F, et al. Can J Urol. 2006 Jun;13 Suppl 3:16-24. Can J Urol. 2006. PMID: 16818008 Review.

6

Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases.

Lessard L, Karakiewicz PI, Bellon-Gagnon P, Alam-Fahmy M, Ismail HA, Mes-Masson AM, Saad F. Lessard L, et al. Among authors: saad f. Clin Cancer Res. 2006 Oct 1;12(19):5741-5. doi: 10.1158/1078-0432.CCR-06-0330. Clin Cancer Res. 2006. PMID: 17020979

7

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

Gallina A, Jeldres C, Chun FK, Shariat SF, Briganti A, Walz J, Roehrborn CG, Saad F, Huland H, Graefen M, Montorsi F, Karakiewicz PI. Gallina A, et al. Among authors: saad f. Eur Urol. 2007 Nov;52(5):1374-80. doi: 10.1016/j.eururo.2006.12.010. Epub 2006 Dec 11. Eur Urol. 2007. PMID: 17174466

8

Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer.

Péant B, Diallo JS, Lessard L, Delvoye N, Le Page C, Saad F, Mes-Masson AM. Péant B, et al. Among authors: saad f. Mol Cancer Res. 2007 Jan;5(1):87-94. doi: 10.1158/1541-7786.MCR-06-0144. Mol Cancer Res. 2007. PMID: 17259348

9

NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells.

Lessard L, Saad F, Le Page C, Diallo JS, Péant B, Delvoye N, Mes-Masson AM. Lessard L, et al. Among authors: saad f. Cell Signal. 2007 May;19(5):1093-100. doi: 10.1016/j.cellsig.2006.12.012. Epub 2007 Jan 11. Cell Signal. 2007. PMID: 17292587

10

Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.

Hutterer G, Perrotte P, Gallina A, Walz J, Jeldres C, Traumann M, Suardi N, Saad F, Bénard F, Valiquette L, McCormack M, Graefen M, Montorsi F, Karakiewicz PI. Hutterer G, et al. Among authors: saad f. Eur J Cancer. 2007 May;43(7):1180-7. doi: 10.1016/j.ejca.2007.01.005. Epub 2007 Feb 9. Eur J Cancer. 2007. PMID: 17292604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,414 results

Search Page

Filters